Corient Private Wealth LLC

Position in FATE — Fate Therapeutics Inc

CIK 1948780 MIAMI, FL

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,838

+$6,605 QoQ

Shares Held

29,865

+0.1% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 99.49773982923155.ToString("F0")% Shared 0.ToString("F0")% None 0.5022601707684581.ToString("F0")%

Healthcare · as of Mar 31, 2026

Corient Private Wealth LLC holds $187,873,632 across 105 Biotechnology names. FATE ranks #101 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	86,492	$38,622,137
2	IONS	Ionis Pharmaceuticals Inc	196,599	$14,762,618
3	REGN	Regeneron Pharmaceuticals, Inc.	18,073	$13,963,922
4	HALO	Halozyme Therapeutics, Inc.	190,684	$12,323,906
5	ALNY	Alnylam Pharmaceuticals, Inc.	25,718	$8,509,313
6	OMER	Omeros Corp	801,411	$8,462,900
7	RPRX	Royalty Pharma plc	116,377	$5,582,604
8	RLMD	Relmada Therapeutics, Inc.	719,582	$5,008,290

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,838	29,865	+0.1%	Shares	Sole	2026-05-15
2025-12-31	$29,233	29,830	+0.4%	Shares	Sole	2026-03-09
2025-06-30	$33,290	29,724	+0.3%	Shares	Sole	2025-09-26
2025-03-31	$23,422	29,649	0.0%	Shares	Sole	2025-05-14
2024-12-31	$48,920	29,649	0.0%	Shares	Sole	2025-02-10
2024-09-30	$103,771	29,649	0.0%	Shares	Sole	2024-11-12
2024-06-30	$97,248	29,649	-20.9%	Shares	Sole	2024-08-13
2024-03-31	$275,272	37,503	+26.5%	Shares	Sole	2024-05-09
2023-12-31	$110,887	29,649	-5.1%	Shares	Sole	2024-02-09
2023-09-30	$66,266	31,258	+0.2%	Shares	Sole	2023-11-03
2023-06-30	$148,440	31,185	-18.5%	Shares	Sole	2023-08-10
2023-03-31	$218,184	38,278	+24.9%	Shares	Sole	2023-05-15
2022-12-31	$309,157	30,640	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.